Go to the list of all blogs
Alicia's Avatar
published in Blogs
May 05, 2026
BellRing Brands (BRBR) Shares Drop -43% After Earnings Miss and Guidance Cut

BellRing Brands (BRBR) Shares Drop -43% After Earnings Miss and Guidance Cut

Key Takeaways

  • BellRing Brands (BRBR) shares plunged 43.09% to $9.88 in the most recent trading session.
  • The primary catalyst was a disappointing Q2 fiscal 2026 earnings report, with adjusted EPS of $0.14 missing estimates of $0.31 by 55% and revenue of $598.7 million falling short of $608.8 million expectations.
  • Company cut its full-year 2026 revenue guidance to $2.33-$2.37 billion from prior $2.41-$2.46 billion, citing promotional headwinds, input cost inflation, and freight pressures.
  • Trading volume surged to over 12 million shares, well above the three-month average of 3.56 million.
  • The move diverged sharply from consumer staples peers and the XLP ETF, which showed minimal change.
  • Traders are watching the earnings conference call for further commentary on margin pressures and recovery plans.

The Sharp Decline in BRBR Shares

BellRing Brands, Inc. (BRBR), known for its convenient nutrition products such as Premier Protein shakes and Dymatize powders, experienced a significant drop in its stock price. Shares fell 43.09% to $9.88 during Monday's trading session, down from a prior close of $17.36. This reaction stemmed directly from the company's second-quarter fiscal 2026 earnings miss and a downward revision to its full-year guidance. From what I see, investors are clearly concerned about slowing growth and profitability pressures in the protein nutrition segment.

Breaking Down the Earnings Miss and Revised Outlook

In Q2 fiscal 2026, BellRing Brands reported net sales of $598.7 million, reflecting just a 1.8% year-over-year increase but missing the consensus estimate of $598.8 million. Adjusted EPS came in at $0.14, representing a 55.3% shortfall against expectations of $0.31. One thing that stands out is the sharp contraction in gross margins, which fell to 22.7% from 34.5% a year earlier, driven by higher protein and freight costs along with increased promotional activity.

The company also adjusted its fiscal 2026 outlook, narrowing revenue guidance to $2.33-$2.37 billion—about 2.9% below prior analyst forecasts—and Adjusted EBITDA to $315-$335 million. Management pointed to ongoing consumer headwinds, inflation on key inputs, and investments in advertising as key factors, noting that the guidance does not assume recovery from recent inventory issues. I also checked this using Tickeron’s AI Screener to see how BRBR compares to others in the industry, and the margin pressures appear more acute here.

Trading Volume and Market Reaction

Trading volume spiked to 12 million shares, more than triple the three-month average of 3.56 million, indicating strong selling pressure following the earnings release. This plunge stood out against the broader market and sector, where the Consumer Staples Select Sector SPDR ETF (XLP) remained flat around $83.64. Among peers, Post Holdings (POST) dipped slightly to $102.09, Monster Beverage (MNST) edged up to $76.27, and USANA Health (USNA) held near $18.60, highlighting the company-specific nature of BRBR's decline. Technically, shares broke below key support near $17, with heightened volatility despite a beta of 0.81.

Exploring Tickeron’s Trending AI Robots

In my own research process, I often turn to Tickeron’s Trending AI Robots page, which highlights the platform's top-performing AI-driven trading bots tailored to current market conditions. Tickeron provides hundreds of these AI bots, covering thousands of tickers across strategies like momentum, mean reversion, and pattern recognition, across various timeframes and performance metrics. Only the strongest, most adaptive ones make the curated list, which is particularly useful in volatile situations like earnings-driven moves. I’m watching this closely because it helps me identify tools that deliver data-backed insights without relying on guesswork—check out the real-time rankings, backtested results, and bot details there for yourself.

Looking Ahead for BRBR

Investors will want to tune into the Q2 earnings conference call at 8:30 a.m. ET for more details on cost management and demand trends. The next quarterly results are scheduled for early August 2026. In my view, analyst consensus is turning cautious after the guidance cut, with emphasis on execution in a competitive protein category. Broader sector risks persist, including inflation and shifting consumer preferences toward value options. Uncertainties around promotional effectiveness and supply chain costs remain, though long-term potential exists in household penetration for ready-to-drink nutrition if margins can stabilize. This is important because it underscores the need for disciplined monitoring.

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.

Related Ticker: BRBR

Contributor

Alicia's AvatarAlicia|Beginner

BRBR's Indicator enters downward trend

The Aroon Indicator for BRBR entered a downward trend on September 18, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 183 similar instances where the Aroon Indicator formed such a pattern. In 139 of the 183 cases the stock moved lower. This puts the odds of a downward move at 76%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 08, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BRBR as a result. In 58 of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 70%.

The Moving Average Convergence Divergence Histogram (MACD) for BRBR turned negative on September 08, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 33 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 66%.

BRBR moved below its 50-day moving average on August 12, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for BRBR crossed bearishly below the 50-day moving average on August 17, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 67%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BRBR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 72%.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 8 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +4.97% 3-day Advance, the price is estimated to grow further. Considering data from situations where BRBR advanced for three days, in 204 of 300 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.

BRBR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 37 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 49 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-0.542) is normal, around the industry mean (5.411). P/E Ratio (6.324) is within average values for comparable stocks, (32.813). Projected Growth (PEG Ratio) (1.340) is also within normal values, averaging (8.465). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (0.462) is also within normal values, averaging (4.925).

The Tickeron Price Growth Rating for this company is 85 (best 1 - 100 worst), indicating slightly worse than average price growth. BRBR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BRBR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

Notable companies

The most notable companies in this group are Kraft Heinz Company (The) (NYSE:KHC), General Mills (NYSE:GIS), The Campbell's Company (NASDAQ:CPB), Beyond Meat Inc. (NASDAQ:BYND).

Industry description

Companies in this industry usually make a diverse range of agricultural and/or processed food. Some prominent names in this segment are Mondelez International, which makes chocolates, biscuits, cookies etc. The Kraft Heinz Company specializes in ketchups, sauces, fruit drink pouches and many more. General Mills, Inc. sells flour and cereal. Kellogg is famous for its snacks and breakfast cereal. And so on down the line. As more and more consumers are looking for healthier options in food in recent years, several legacy food companies have responded by revamping brands to include organic and no-added-sugar versions, and/or acquiring healthy food firms, and even streamlining operations.

Market Cap

The average market capitalization across the Food: Major Diversified Industry is 3.04B. The market cap for tickers in the group ranges from 68.81K to 237.79B. NSRGY holds the highest valuation in this group at 237.79B. The lowest valued company is THRC at 68.81K.

High and low price notable news

The average weekly price growth across all stocks in the Food: Major Diversified Industry was -2%. For the same Industry, the average monthly price growth was -7%, and the average quarterly price growth was -8%. CLNN experienced the highest price growth at 22%, while STKH experienced the biggest fall at -19%.

Volume

The average weekly volume growth across all stocks in the Food: Major Diversified Industry was 22%. For the same stocks of the Industry, the average monthly volume growth was 92% and the average quarterly volume growth was -24%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 48
P/E Growth Rating: 62
Price Growth Rating: 64
SMR Rating: 78
Profit Risk Rating: 92
Seasonality Score: -13 (-100 ... +100)
View a ticker or compare two or three
BRBR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry FoodMajorDiversified

Profile
Details
Industry
N/A
Address
2503 South Hanley Road
Phone
+1 314 644-7600
Employees
530
Web
https://www.bellring.com
Interact to see
Advertisement
Shares of ALDX are down about 73.02% in premarket trading, plunging from a prior close near 4.13 dollars to roughly 1.11 dollars after a major regulatory setback. The collapse follows fresh confirmation that the U.S. Food and Drug Administration has again declined to approve reproxalap for dry eye disease, issuing another Complete Response Letter that questions efficacy.
Shares of MVST are down about 25% in premarket trading today compared with the prior close. The slide follows a sharp reassessment of the company’s outlook as investors react to new information and recent volatility in high‑beta battery and EV names.
Solaris Energy Infrastructure’s stock SEI jumped roughly 13% in today’s session, extending a sharp recent rebound from early-March lows. The move is driven by ongoing post-earnings momentum after strong Q4 and full‑year 2025 results and raised guidance highlighted rapid growth in its power solutions business.
Shares of LMND are trading approximately +10% higher intraday on Tuesday, March 17, 2026, rising from a prior close of $57.74 to around $63.51. Primary catalyst: Morgan Stanley upgraded LMND to an 'Overweight' rating and raised its price target to $85 from $80.
Shares of ICHR surged approximately +15% intraday on Tuesday, March 17, 2026, trading near $48.98 versus a prior closing price of $42.59. The primary catalyst is a high-profile analyst upgrade by Stifel, with analyst Brian Chin upgrading the stock to Buy citing improved cyclical strength and conviction in the company's revenue and margin trajectory.
NBIS shares are down approximately 10.00% in Tuesday's session, falling from a prior close of $129.85 to around $116.87. The primary catalyst is Nebius Group's pre-market announcement of a proposed $3.75 billion convertible senior notes offering, sparking dilution concerns.
TME shares fell over 20% today, with the stock sliding from the mid‑$15s toward the low‑$13s in the wake of its Q4 2025 report and earnings call, extending a pre‑market drop of roughly 12–13%.
HUYA shares fell over 11% today, dropping from the mid‑$3 range toward the low‑$3s following the company’s Q4 2025 earnings release before the U.S. market open. Q4 total net revenues rose about 16% year over year to roughly CNY 1.74 billion, with full‑year 2025 revenues up around 7% to CNY 6.5 billion, but the market had already priced in a rebound after a difficult 2024.​
CWCO fell over 9% today, trading around the low‑$31 range versus recent levels in the mid‑$30s to near $39, as the market reacted negatively to Q4 2025 results and forward commentary. Full‑year 2025 results showed stable earnings and dividend growth but a roughly 9% decline in services revenue to about $46.3 million, reflecting a slowdown in project‑based construction work.
SMTC shares dropped over 8% today after the company reported Q4 results that met or modestly beat Street estimates but showed the slowest year‑over‑year revenue growth in several quarters, at about 9.3% to roughly $274–275 million.
AXTI shares slipped more than 6% today, reversing part of a powerful rally that had recently driven the stock to a 52‑week high above $47 and more than doubled its price year‑to‑date. Q4 2025 revenue of about $23.0 million missed consensus by roughly $1.2 million and fell 8–18% year over year and sequentially, while the company posted another GAAP net loss of around $3.5 million (–$0.08 per share).
Shares of SailPoint, Inc. (SAIL) are tumbling approximately 12% in premarket trading on March 18, 2026, after the company released its fiscal fourth-quarter and full-year 2026 results before the market opened. While Q4 revenue came in slightly above consensus at $295 million (+23% year-over-year), investors were rattled by disappointing forward guidance for fiscal 2027.
Shares of KC surged approximately +17% in premarket trading on March 18, 2026, from a prior close of $13.12 to approximately $15.35. The primary catalyst is Kingsoft Cloud's release of its unaudited Q4 and full-year 2025 financial results before the U.S. market open, which appear to have significantly exceeded analyst expectations.
AngloGold Ashanti (AU) shares tumbled approximately 7% in premarket trading on March 18, 2026, extending a multi-week downtrend that has erased nearly 20% of the stock's value since late January highs. The primary catalyst driving the decline is persistent investor concern over AngloGold's lowered 2026 production guidance, with the company projecting gold output of 2.80–3.17 million ounces — a roughly 3% decline from its 2025 production of 3.1 million ounces.
AAOI shares surged approximately 10.90% in premarket trading on March 18, 2026, rising from a prior close of $86.33 to $95.74. The primary catalyst is strong positive sentiment generated at OFC 2026 — the Optical Fiber Communications Conference and Exhibition — where Applied Optoelectronics unveiled breakthrough laser and transceiver technology for next-generation AI data center infrastructure.
LITE shares surged approximately +12% in early Wednesday trading on March 18, 2026, with the stock changing hands near $727 compared to a prior session close of $649.56. The primary near-term catalyst is Lumentum's S&P 500 index inclusion, effective March 23, 2026, triggering front-running by institutional investors and mandatory buying by passive index funds.
Shares of New Era Energy & Digital, Inc. (NUAI) are trading down approximately 17% during today's session, with the prior close sitting at $5.56. The decline follows the company's March 17 business update conference call and webcast, held after market hours, during which management discussed the recently filed fiscal year 2025 annual report (Form 10-K).
Shares of Regencell Bioscience Holdings (RGC) are up approximately +16% intraday on March 18, 2026, trading at $26.56 against a prior close of $22.97. No single company-specific press release is driving today's move; the rally is primarily fueled by retail-driven momentum and short squeeze mechanics.
A jump in the Producer Price Index from 0.3% to around 0.7% month‑over‑month signals that wholesale inflation is re‑accelerating, delaying Fed rate‑cut hopes and reviving the “higher for longer” rates narrative.business. Likely winners in this environment include energy and commodity producers (XOM, CVX, TTE, COP), inflation‑resilient financials (JPM, BAC), and real‑asset plays like pipelines and infrastructure, which can pass through higher prices; ETFs like XLE, XOP, XLF, DBA, GLD offer diversified exposure.
BGSI fell more than 11% today, pulling back from recent levels around the high‑$150s as investors reassessed the risk‑reward following the Q4 2025 print and major U.S. expansion plans. Full‑year 2025 sales rose 2.4% to US$3.14 billion, but same‑store sales declined 0.2%, while reported net earnings fell 25% to US$18.4 million due to US$22.6 million in acquisition and transformation costs.